NEUROMUSCULAR DISEASES

This study tested a new medicine called apitegromab in 188 children (ages 2–21) with later-onset spinal muscular atrophy (SMA types 2 and 3) who were already taking standard treatments. The goal was to see if adding apitegromab could further improve muscle function and movement. …

This study tested a drug called ataluren in 360 boys (age 5 and older) with a specific genetic form of Duchenne muscular dystrophy caused by a 'nonsense mutation.' The goal was to see if ataluren could help them walk farther over 72 weeks compared to a placebo. Participants conti…

This study looked at the long-term safety of a drug called AOC 1001 in adults with myotonic dystrophy type 1 (DM1), a genetic muscle disease. 37 people who completed an earlier study received multiple doses of the drug by IV. Researchers tracked side effects and measured drug lev…

This study tested whether the EXOPULSE Mollii suit, which delivers mild electrical pulses, can reduce pain, fatigue, and improve mood in people with fibromyalgia. Twenty-eight adults wore either the active suit or a sham (inactive) suit for two weeks. The goal was to see if the s…

This study tested whether online peer support helps family caregivers of people with neuromuscular disease feel more capable and less alone. About 100 Canadian caregivers were randomly assigned to receive virtual peer support or not. The goal was to see if talking with someone wh…

This study looked at 42 male football players to see if a past hamstring strain affects how muscles work together. Researchers measured muscle activity during exercises and found that even after healing, certain back and hip muscles don't activate as well. This may explain why so…

This study looked at how muscles use oxygen during exercise in people with different neuromuscular diseases compared to healthy volunteers. Seventeen participants did a knee exercise while a device measured muscle oxygen levels. The goal was to understand if oxygen use is impaire…